Drug shortage database
Direct summary
This database view lists published medication pages with procurement-oriented shortage context. It is not a government shortage registry and not real-time stock data. Availability depends on market conditions and regulations.
Browse by category
- AnesthesiaPerioperative medicines including controlled substances with strict handling and documentation requirements.
- CardiologyMedicines used in interventional and acute cardiology pathways where hospital stock and allocation matter.
- Critical careMedicines used in ICUs, anesthesia, and perioperative settings where supply continuity is essential.
- Emergency medicineResuscitation, analgesia, and airway medicines frequently stocked for emergency departments and crash carts.
- EndocrinologyHormonal therapies including insulin and vitamin B12 formulations used across inpatient and outpatient care.
- Hospital injectablesSterile injectable medicines used across departments where batch shortages can affect multiple services.
- Infectious diseaseAntibiotics, antivirals, and related therapies where formulary access and supply vary by region.
- NeurologyMedicines used in neurological care where product choice depends on formulation and local availability.
- OncologyAntineoplastic and supportive medicines frequently subject to allocation, regional shortages, or complex sourcing.
- OphthalmologyOphthalmic therapies, including specialty injections used in retinal care where cold chain and sourcing matter.
- Pain managementAnalgesic and related therapies used in inpatient and procedural settings under institutional controls.
- PsychiatryMedicines used in psychiatric care, including long-acting injectable formulations with strict handling rules.
- Rare diseaseTherapies for rare conditions where patient populations are small and distribution networks are specialized.
- RespiratoryInhaled and systemic respiratory therapies where device compatibility and regional registration vary.
- Specialty medicinesHigh-complexity products with cold chain, handling, or distribution constraints beyond standard formularies.
- VaccinesImmunization products where national programs, tenders, and cold chain requirements shape availability.
Recently updated entries
- Glycoprotein IIb/IIIa inhibitor used in selected hospital cardiology pathways per label and protocol.
- Branded verteporfin product used in clinician-directed ophthalmic treatment workflows.
- Branded peginterferon product used in specialty programs where local authorization and labeling apply.
- Potent opioid used in anesthesia workflows where institutional protocols and controls apply.
- Ultra short-acting opioid used in anesthesia and monitored settings with strict handling rules.
- Injectable medicine used in selected acute care scenarios per institutional protocol and labeling.
- Injectable opioid used in inpatient analgesia pathways where institutional policies govern use.
- Injectable opioid analgesic used in controlled hospital workflows with strict custody and protocol requirements.
- Antineoplastic used in selected hematologic malignancies under specialist supervision.
- Short-acting bronchodilator used in acute bronchospasm management per clinical pathways.
- Sedative used in ICU and procedural sedation settings under monitoring protocols.
- Local anesthetic used in surgical and obstetric anesthesia workflows per institutional protocol.